You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 293 No. 2, January 12, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (98)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Diabetes Mellitus
 •Alert me on articles by topic

Fasting Serum Glucose Level and Cancer Risk in Korean Men and Women

Sun Ha Jee, PhD, MHS; Heechoul Ohrr, MD, PhD; Jae Woong Sull, PhD, MHS; Ji Eun Yun, MPH; Min Ji, MPH; Jonathan M. Samet, MD, MS

JAMA. 2005;293:194-202.

Context  Diabetes is a serious and costly disease that is becoming increasingly common in many countries. The role of diabetes as a cancer risk factor remains unclear.

Objective  To examine the relationship between fasting serum glucose and diabetes and risk of all cancers and specific cancers in men and women in Korea.

Design, Setting, and Participants  Ten-year prospective cohort study of 1 298 385 Koreans (829 770 men and 468 615 women) aged 30 to 95 years who received health insurance from the National Health Insurance Corp and had a biennial medical evaluation in 1992-1995 (with follow-up for up to 10 years).

Main Outcome Measures  Death from cancer and registry-documented incident cancer or hospital admission for cancer.

Results  During the 10 years of follow-up, there were 20 566 cancer deaths in men and 5907 cancer deaths in women. Using Cox proportional hazards models and controlling for smoking and alcohol use, the stratum with the highest fasting serum glucose (≥140 mg/dL [≥7.8 mmol/L]) had higher death rates from all cancers combined (hazard ratio [HR], 1.29; 95% confidence interval [CI], 1.22-1.37 in men and HR, 1.23; 95% CI, 1.09-1.39 in women) compared with the stratum with the lowest level (<90 mg/dL [<5.0 mmol/L]). By cancer site, the association was strongest for pancreatic cancer, comparing the highest and lowest strata in men (HR, 1.91; 95% CI, 1.52-2.41) and in women (HR, 2.05; 95% CI, 1.43-2.93). Significant associations were also found for cancers of the esophagus, liver, and colon/rectum in men and of the liver and cervix in women, and there were significant trends with glucose level for cancers of the esophagus, colon/rectum, liver, pancreas, and bile duct in men and of the liver and pancreas in women. Of the 26 473 total cancer deaths in men and women, 848 were estimated as attributable to having a fasting serum glucose level of less than 90 mg/dL. For cancer incidence, the general patterns reflected those found for mortality. For persons with a diagnosis of diabetes or a fasting serum glucose level greater than 125 mg/dL (6.9 mmol/L), risks for cancer incidence and mortality were generally elevated compared with those without diabetes.

Conclusion  In Korea, elevated fasting serum glucose levels and a diagnosis of diabetes are independent risk factors for several major cancers, and the risk tends to increase with an increased level of fasting serum glucose.


Author Affiliations: Department of Epidemiology and Health Promotion, Graduate School of Public Health (Dr Jee and Mss Yun and Ji), Department of Preventive Medicine and Public Health, College of Medicine (Dr Ohrr), and Department of Public Health, Graduate School (Dr Sull), Yonsei University, Seoul, Korea; and Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Md (Drs Jee and Samet).


RELATED LETTERS

Fasting Serum Glucose Level and Cancer Risk in Korean Men and Women
Subrata D. Nath, Samy L. Habib, and Hanna E. Abboud
JAMA. 2005;293(18):2210-2211.
EXTRACT | FULL TEXT  

Fasting Serum Glucose Level and Cancer Risk in Korean Men and Women—Reply
Sun Ha Jee, Heechoul Ohrr, Jae Woong Sull, Ji Eun Yun, Ji Min, and Jonathan M. Samet
JAMA. 2005;293(18):2211.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Hyperglycemia, Obesity, and Cancer Risks on the Horizon
Kathleen A. Cooney and Stephen B. Gruber
JAMA. 2005;293(2):235-236.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prediagnostic Adiponectin Concentrations and Pancreatic Cancer Risk in Male Smokers
Stolzenberg-Solomon et al.
Am J Epidemiol 2008;0:kwn221v1-kwn221.
ABSTRACT | FULL TEXT  

Independent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus
Yang et al.
CMAJ 2008;179:427-437.
ABSTRACT | FULL TEXT  

Weight change and cancer risk in a cohort of more than 65 000 adults in Austria
Rapp et al.
Ann Oncol 2008;19:641-648.
ABSTRACT | FULL TEXT  

Cardiorespiratory Fitness as a Predictor of Cancer Mortality Among Men With Pre-Diabetes and Diabetes
Thompson et al.
Diabetes Care 2008;31:764-769.
ABSTRACT | FULL TEXT  

Glycemic Status and Risk of Prostate Cancer
Darbinian et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:628-635.
ABSTRACT | FULL TEXT  

Adiposity, Physical Activity, and Pancreatic Cancer in the National Institutes of Health-AARP Diet and Health Cohort
Stolzenberg-Solomon et al.
Am J Epidemiol 2008;167:586-597.
ABSTRACT | FULL TEXT  

Population-based Case-Control Study of Diabetes and Breast Cancer Risk in Hispanic and Non-Hispanic White Women Living in US Southwestern States
Rollison et al.
Am J Epidemiol 2008;167:447-456.
ABSTRACT | FULL TEXT  

Pancreatic Cancer and Factors Associated with the Insulin Resistance Syndrome in the Korean Cancer Prevention Study
Berrington de Gonzalez et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:359-364.
ABSTRACT | FULL TEXT  

Smoking and Type 2 Diabetes: Underrecognized Risks and Disease Burden
Ding and Hu
JAMA 2007;298:2675-2676.
FULL TEXT  

Association of Diet-Induced Hyperinsulinemia With Accelerated Growth of Prostate Cancer (LNCaP) Xenografts
Venkateswaran et al.
JNCI J Natl Cancer Inst 2007;99:1793-1800.
ABSTRACT | FULL TEXT  

Dietary glycemic load, added sugars, and carbohydrates as risk factors for pancreatic cancer: the Multiethnic Cohort Study
Nothlings et al.
Am. J. Clin. Nutr. 2007;86:1495-1501.
ABSTRACT | FULL TEXT  

Prediagnosis Smoking, Obesity, Insulin Resistance, and Second Primary Cancer Risk in Male Cancer Survivors: National Health Insurance Corporation Study
Min Park et al.
JCO 2007;25:4835-4843.
ABSTRACT | FULL TEXT  

Prediagnostic Plasma C-Peptide and Pancreatic Cancer Risk in Men and Women
Michaud et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:2101-2109.
ABSTRACT | FULL TEXT  

Symposium introduction: metabolic syndrome and the onset of cancer
Zhou et al.
Am. J. Clin. Nutr. 2007;86:817S-819S.
ABSTRACT | FULL TEXT  

Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence
Xue and Michels
Am. J. Clin. Nutr. 2007;86:823S-835S.
ABSTRACT | FULL TEXT  

Circulating Insulin-Like Growth Factor Binding Protein-1 and the Risk of Pancreatic Cancer
Wolpin et al.
Cancer Res. 2007;67:7923-7928.
ABSTRACT | FULL TEXT  

Is Metabolic Syndrome A Risk Factor for Colorectal Adenoma?
Kim et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:1543-1546.
ABSTRACT | FULL TEXT  

Association between glycosylated hemoglobin and cancer risk: a New Zealand linkage study
Travier et al.
Ann Oncol 2007;18:1414-1419.
ABSTRACT | FULL TEXT  

Insulin Potentiates Ca2+ Signaling and Phosphatidylinositol 4,5-Bisphosphate Hydrolysis Induced by Gq Protein-Coupled Receptor Agonists through an mTOR-Dependent Pathway
Kisfalvi et al.
Endocrinology 2007;148:3246-3257.
ABSTRACT | FULL TEXT  

Trends in pancreatic cancer incidence in nine SEER Cancer Registries, 1973 2002
Zhang et al.
Ann Oncol 2007;18:1268-1279.
ABSTRACT | FULL TEXT  

Peroxisome proliferator-activated receptor {gamma} agonists inhibit the proliferation and invasion of human colon cancer cells
Shen et al.
Postgrad. Med. J. 2007;83:414-419.
ABSTRACT | FULL TEXT  

Prospective Study of Hyperglycemia and Cancer Risk
Stattin et al.
Diabetes Care 2007;30:561-567.
ABSTRACT | FULL TEXT  

Interaction of Factors Related to the Metabolic Syndrome and Vitamin D on Risk of Prostate Cancer
Tuohimaa et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:302-307.
ABSTRACT | FULL TEXT  

A Prospective Study of Periodontal Disease and Pancreatic Cancer in US Male Health Professionals
Michaud et al.
JNCI J Natl Cancer Inst 2007;99:171-175.
ABSTRACT | FULL TEXT  

The Effect of Modifiable Risk Factors on Pancreatic Cancer Mortality in Populations of the Asia-Pacific Region
Ansary-Moghaddam et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:2435-2440.
ABSTRACT | FULL TEXT  

Consumption of sugar and sugar-sweetened foods and the risk of pancreatic cancer in a prospective study.
Larsson et al.
Am. J. Clin. Nutr. 2006;84:1171-1176.
ABSTRACT | FULL TEXT  

Impact of Prediagnosis Smoking, Alcohol, Obesity, and Insulin Resistance on Survival in Male Cancer Patients: National Health Insurance Corporation Study
Park et al.
JCO 2006;24:5017-5024.
ABSTRACT | FULL TEXT  

The Metabolic Syndrome: A High-Risk State for Cancer?
Cowey and Hardy
Am. J. Pathol. 2006;169:1505-1522.
ABSTRACT | FULL TEXT  

Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan.
Inoue et al.
Arch Intern Med 2006;166:1871-1877.
ABSTRACT | FULL TEXT  

Third Annual World Congress on the Insulin Resistance Syndrome: Associated conditions.
Bloomgarden
Diabetes Care 2006;29:2165-2174.
FULL TEXT  

Body-Mass Index and Mortality in Korean Men and Women
Jee et al.
NEJM 2006;355:779-787.
ABSTRACT | FULL TEXT  

Anthropometry, Physical Activity, and the Risk of Pancreatic Cancer in the European Prospective Investigation into Cancer and Nutrition.
Berrington de Gonzalez et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:879-885.
ABSTRACT | FULL TEXT  

A Prospective Study of Hemoglobin A1c Concentrations and Risk of Breast Cancer in Women.
Lin et al.
Cancer Res. 2006;66:2869-2875.
ABSTRACT | FULL TEXT  

Association Between Circulating White Blood Cell Count and Cancer Mortality: A Population-Based Cohort Study
Shankar et al.
Arch Intern Med 2006;166:188-194.
ABSTRACT | FULL TEXT  

Diabetes Mellitus and Risk of Colorectal Cancer in the Singapore Chinese Health Study
Seow et al.
JNCI J Natl Cancer Inst 2006;98:135-138.
ABSTRACT | FULL TEXT  

Insulin, Glucose, Insulin Resistance, and Pancreatic Cancer in Male Smokers
Stolzenberg-Solomon et al.
JAMA 2005;294:2872-2878.
ABSTRACT | FULL TEXT  

White Blood Cell Count and Risk for All-Cause, Cardiovascular, and Cancer Mortality in a Cohort of Koreans
Jee et al.
Am J Epidemiol 2005;162:1062-1069.
ABSTRACT | FULL TEXT  

Diabetes Mellitus and Risk of Colorectal Cancer: A Meta-Analysis
Larsson et al.
JNCI J Natl Cancer Inst 2005;97:1679-1687.
ABSTRACT | FULL TEXT  

Reduced Screening Mammography Among Women With Diabetes
Lipscombe et al.
Arch Intern Med 2005;165:2090-2095.
ABSTRACT | FULL TEXT  

Naturopathic Approaches
Uzick
Integr Cancer Ther 2005;4:253-258.
 

Fasting Serum Glucose Level and Cancer Risk in Korean Men and Women
Nath et al.
JAMA 2005;293:2210-2211.
FULL TEXT  

Advancing a Traditional View of Osteopathic Medicine Through Clinical Practice
Rogers
JAOA: Journal of the American Osteopathic Association 2005;105:255-259.
FULL TEXT  

Raised glucose concentrations and diabetes are associated with cancer risk
Mayor
BMJ 2005;330:111-111.
FULL TEXT  

Hyperglycemia, Obesity, and Cancer Risks on the Horizon
Cooney and Gruber
JAMA 2005;293:235-236.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.